12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet

RxCUI
2119482
RxNorm name
12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet
Term type
SCD
Status
Active
Updated
2026-11-14 08:21:38

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042019
Active start
042019
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
chlorpheniramine maleate8 MG / 1 EACHchlorpheniraminechlorpheniramine maleate
phenylephrine hydrochloride25 MG / 1 EACHphenylephrinephenylephrine hydrochloride
methscopolamine nitrate2.5 MG / 1 EACHmethscopolaminemethscopolamine nitrate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
chlorpheniramine2400
phenylephrine8163
methscopolamine89785

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
59196003201rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCS01FAAnticholinergicsATC1-4methscopolamine
ATCA03BBBelladonna alkaloids, semisynthetic, quaternary ammonium compoundsATC1-4methscopolamine
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR06ABSubstituted alkylaminesATC1-4chlorpheniramine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
FDASPLN0000175574AnticholinergicEPChas_epcmethscopolamine
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epcchlorpheniramine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moamethscopolamine
MEDRTD002744ChlorpheniramineCHEMhas_ingredientchlorpheniramine maleate
MEDRTD002744ChlorpheniramineCHEMhas_ingredientchlorpheniramine
MEDRTD019832N-MethylscopolamineCHEMhas_ingredientmethscopolamine nitrate
MEDRTD019832N-MethylscopolamineCHEMhas_ingredientmethscopolamine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD003093Colitis, UlcerativeDISEASEci_withmethscopolamine nitrate
MEDRTD003093Colitis, UlcerativeDISEASEci_withmethscopolamine
MEDRTD004342Drug HypersensitivityDISEASEci_withmethscopolamine
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorpheniramine
MEDRTD004342Drug HypersensitivityDISEASEci_withmethscopolamine nitrate
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorpheniramine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD004380Duodenal ObstructionDISEASEci_withchlorpheniramine
MEDRTD004380Duodenal ObstructionDISEASEci_withchlorpheniramine maleate
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD005901GlaucomaDISEASEci_withmethscopolamine nitrate
MEDRTD005901GlaucomaDISEASEci_withmethscopolamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withchlorpheniramine maleate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withchlorpheniramine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006470HemorrhageDISEASEci_withmethscopolamine nitrate
MEDRTD006470HemorrhageDISEASEci_withmethscopolamine
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007231Infant, NewbornDISEASEci_withchlorpheniramine
MEDRTD007231Infant, NewbornDISEASEci_withchlorpheniramine maleate
MEDRTD007234Infant, PrematureDISEASEci_withchlorpheniramine
MEDRTD007234Infant, PrematureDISEASEci_withchlorpheniramine maleate
MEDRTD007415Intestinal ObstructionDISEASEci_withmethscopolamine nitrate
MEDRTD007415Intestinal ObstructionDISEASEci_withmethscopolamine
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withmethscopolamine
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withmethscopolamine nitrate
MEDRTD009157Myasthenia GravisDISEASEci_withmethscopolamine nitrate
MEDRTD009157Myasthenia GravisDISEASEci_withmethscopolamine
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD010437Peptic UlcerDISEASEci_withchlorpheniramine maleate
MEDRTD010437Peptic UlcerDISEASEci_withchlorpheniramine
MEDRTD010437Peptic UlcerDISEASEmay_treatmethscopolamine nitrate
MEDRTD010437Peptic UlcerDISEASEmay_treatmethscopolamine
MEDRTD011470Prostatic HyperplasiaDISEASEci_withchlorpheniramine maleate
MEDRTD011470Prostatic HyperplasiaDISEASEci_withchlorpheniramine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatchlorpheniramine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatchlorpheniramine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD013224Status AsthmaticusDISEASEci_withchlorpheniramine maleate
MEDRTD013224Status AsthmaticusDISEASEci_withchlorpheniramine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withchlorpheniramine maleate
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withchlorpheniramine
MEDRTD014581UrticariaDISEASEmay_treatchlorpheniramine maleate
MEDRTD014581UrticariaDISEASEmay_treatchlorpheniramine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000175370Cholinergic AntagonistsMOAhas_moamethscopolamine nitrate
MEDRTN0000175370Cholinergic AntagonistsMOAhas_moamethscopolamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moachlorpheniramine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moachlorpheniramine maleate
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008635Decreased GI MotilityPEhas_pemethscopolamine nitrate
MEDRTN0000008635Decreased GI MotilityPEhas_pemethscopolamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pechlorpheniramine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pechlorpheniramine maleate
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pemethscopolamine
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pemethscopolamine nitrate
MEDRTN0000009820Pupillary DilationPEhas_pemethscopolamine
MEDRTN0000009820Pupillary DilationPEhas_pemethscopolamine nitrate
MEDRTN0000009842Salivation InhibitionPEhas_pemethscopolamine
MEDRTN0000009842Salivation InhibitionPEhas_pemethscopolamine nitrate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESQUANTITY12 HR
NAMESPrescribable Synonymchlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine HCl 25 MG 12HR Extended Release Oral Tablet